Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IV-255 is a selective small molecule inhibitor of the BRG1 bromodomain, heightening DNA damage when administered with Temozolomide and Bleomycin. It also curtails the invasiveness of GBM cells and augments both Temozolomide-induced cell death and Temozolomide's apoptosis-inducing activity [1].
Description | IV-255 is a selective small molecule inhibitor of the BRG1 bromodomain, heightening DNA damage when administered with Temozolomide and Bleomycin. It also curtails the invasiveness of GBM cells and augments both Temozolomide-induced cell death and Temozolomide's apoptosis-inducing activity [1]. |
Molecular Weight | 359.37 |
Formula | C19H19F2N3O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IV-255 Chromatin/Epigenetic Epigenetic Reader Domain inhibitor inhibit